brdu Search Results


95
Bio-Rad anti brdu
Anti Brdu, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti brdu/product/Bio-Rad
Average 95 stars, based on 1 article reviews
anti brdu - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc brdu cell proliferation assay kit
FGF5 and FGF5s compete for binding to FGFBP1 via LLPS and regulate liver regeneration. a <t>BrdU</t> cell <t>proliferation</t> assay results to detect cell proliferation ability in AML12 cells overexpressing the 18 FGFs and treated with rFGFBP1 (10 ng/ml) or rFGFBP1 and FGFBP1Ab (2 μg/ml) ( n = 3). b Hepatic protein levels of FGF5 and FGF5s at the indicated times after partial (2/3) hepatectomy (PHx), with the corresponding quantification ( n = 2). c Representative liver FGFBP1 and FGF5 immunofluorescence results 24 h after acetaminophen (APAP) or saline administration. d Domain structure and the intrinsically disordered tendency of mouse FGF5 and FGF5s. IUPred assigned scores of the disordered tendencies of the sequences between 0 and 1, with scores higher than 0.5 indicating disorder. The amino acid sequence of FGF5 contains one IDR. e Confocal microscopy images of the assembly status of 5 μmol/L purified rFGF5-mCherry, rFGF5s-mCherry, or rΔIDR-mCherry with 0 or 10% PEG. Scale bar = 5 µm. f Images of purified protein colocalization assay on the cell surface via confocal microscopy and representative curves describing the distribution of the relative fluorescence intensities of FGFBP1 (green) and FGF5 or FGF5s (red). Top two panels: rFGFBP1-EGFP (5 nmol/L) with rFGF5-mCherry (20 nmol/L) or rFGF5s-mCherry (10 nmol/L). Bottom three panels: rFGFBP1-EGFP (5 nmol/L) with rFGF5-mCherry (20 nmol/L) and different amounts of rFGF5s (10, 20, or 40 nmol/L). Scale bar = 5 µm. g Representative albumin (ALB, a hepatocellular function marker) immunofluorescence of human liver organoids (HLOs) in the indicated groups. h Measurement of ALB secretion in HLOs ( n = 3). i Size calculation of HLOs in the indicated groups (CON, n = 146; rFGFBP1, n = 157; rFGFBP1 + rFGF5, n = 184). * P < 0.05, *** P < 0.001. FGF5 fibroblast growth factor 5, FGF5s short form of FGF5, FGFBP1 fibroblast growth factor binding protein 1, LLPS liquid–liquid phase separation, IDR intrinsically disordered region, PEG polyethylene glycol, EGFP enhanced green fluorescent protein, DIC differential interference contrast, DAPI 4’,6-diamidino-2-phenylindole, SP signal peptide
Brdu Cell Proliferation Assay Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brdu cell proliferation assay kit/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
brdu cell proliferation assay kit - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology primary antibody solution
FGF5 and FGF5s compete for binding to FGFBP1 via LLPS and regulate liver regeneration. a <t>BrdU</t> cell <t>proliferation</t> assay results to detect cell proliferation ability in AML12 cells overexpressing the 18 FGFs and treated with rFGFBP1 (10 ng/ml) or rFGFBP1 and FGFBP1Ab (2 μg/ml) ( n = 3). b Hepatic protein levels of FGF5 and FGF5s at the indicated times after partial (2/3) hepatectomy (PHx), with the corresponding quantification ( n = 2). c Representative liver FGFBP1 and FGF5 immunofluorescence results 24 h after acetaminophen (APAP) or saline administration. d Domain structure and the intrinsically disordered tendency of mouse FGF5 and FGF5s. IUPred assigned scores of the disordered tendencies of the sequences between 0 and 1, with scores higher than 0.5 indicating disorder. The amino acid sequence of FGF5 contains one IDR. e Confocal microscopy images of the assembly status of 5 μmol/L purified rFGF5-mCherry, rFGF5s-mCherry, or rΔIDR-mCherry with 0 or 10% PEG. Scale bar = 5 µm. f Images of purified protein colocalization assay on the cell surface via confocal microscopy and representative curves describing the distribution of the relative fluorescence intensities of FGFBP1 (green) and FGF5 or FGF5s (red). Top two panels: rFGFBP1-EGFP (5 nmol/L) with rFGF5-mCherry (20 nmol/L) or rFGF5s-mCherry (10 nmol/L). Bottom three panels: rFGFBP1-EGFP (5 nmol/L) with rFGF5-mCherry (20 nmol/L) and different amounts of rFGF5s (10, 20, or 40 nmol/L). Scale bar = 5 µm. g Representative albumin (ALB, a hepatocellular function marker) immunofluorescence of human liver organoids (HLOs) in the indicated groups. h Measurement of ALB secretion in HLOs ( n = 3). i Size calculation of HLOs in the indicated groups (CON, n = 146; rFGFBP1, n = 157; rFGFBP1 + rFGF5, n = 184). * P < 0.05, *** P < 0.001. FGF5 fibroblast growth factor 5, FGF5s short form of FGF5, FGFBP1 fibroblast growth factor binding protein 1, LLPS liquid–liquid phase separation, IDR intrinsically disordered region, PEG polyethylene glycol, EGFP enhanced green fluorescent protein, DIC differential interference contrast, DAPI 4’,6-diamidino-2-phenylindole, SP signal peptide
Primary Antibody Solution, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibody solution/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
primary antibody solution - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc antibody against brdu
FGF5 and FGF5s compete for binding to FGFBP1 via LLPS and regulate liver regeneration. a <t>BrdU</t> cell <t>proliferation</t> assay results to detect cell proliferation ability in AML12 cells overexpressing the 18 FGFs and treated with rFGFBP1 (10 ng/ml) or rFGFBP1 and FGFBP1Ab (2 μg/ml) ( n = 3). b Hepatic protein levels of FGF5 and FGF5s at the indicated times after partial (2/3) hepatectomy (PHx), with the corresponding quantification ( n = 2). c Representative liver FGFBP1 and FGF5 immunofluorescence results 24 h after acetaminophen (APAP) or saline administration. d Domain structure and the intrinsically disordered tendency of mouse FGF5 and FGF5s. IUPred assigned scores of the disordered tendencies of the sequences between 0 and 1, with scores higher than 0.5 indicating disorder. The amino acid sequence of FGF5 contains one IDR. e Confocal microscopy images of the assembly status of 5 μmol/L purified rFGF5-mCherry, rFGF5s-mCherry, or rΔIDR-mCherry with 0 or 10% PEG. Scale bar = 5 µm. f Images of purified protein colocalization assay on the cell surface via confocal microscopy and representative curves describing the distribution of the relative fluorescence intensities of FGFBP1 (green) and FGF5 or FGF5s (red). Top two panels: rFGFBP1-EGFP (5 nmol/L) with rFGF5-mCherry (20 nmol/L) or rFGF5s-mCherry (10 nmol/L). Bottom three panels: rFGFBP1-EGFP (5 nmol/L) with rFGF5-mCherry (20 nmol/L) and different amounts of rFGF5s (10, 20, or 40 nmol/L). Scale bar = 5 µm. g Representative albumin (ALB, a hepatocellular function marker) immunofluorescence of human liver organoids (HLOs) in the indicated groups. h Measurement of ALB secretion in HLOs ( n = 3). i Size calculation of HLOs in the indicated groups (CON, n = 146; rFGFBP1, n = 157; rFGFBP1 + rFGF5, n = 184). * P < 0.05, *** P < 0.001. FGF5 fibroblast growth factor 5, FGF5s short form of FGF5, FGFBP1 fibroblast growth factor binding protein 1, LLPS liquid–liquid phase separation, IDR intrinsically disordered region, PEG polyethylene glycol, EGFP enhanced green fluorescent protein, DIC differential interference contrast, DAPI 4’,6-diamidino-2-phenylindole, SP signal peptide
Antibody Against Brdu, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibody against brdu/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
antibody against brdu - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

94
Rockland Immunochemicals antibody rabbit anti brdu
FGF5 and FGF5s compete for binding to FGFBP1 via LLPS and regulate liver regeneration. a <t>BrdU</t> cell <t>proliferation</t> assay results to detect cell proliferation ability in AML12 cells overexpressing the 18 FGFs and treated with rFGFBP1 (10 ng/ml) or rFGFBP1 and FGFBP1Ab (2 μg/ml) ( n = 3). b Hepatic protein levels of FGF5 and FGF5s at the indicated times after partial (2/3) hepatectomy (PHx), with the corresponding quantification ( n = 2). c Representative liver FGFBP1 and FGF5 immunofluorescence results 24 h after acetaminophen (APAP) or saline administration. d Domain structure and the intrinsically disordered tendency of mouse FGF5 and FGF5s. IUPred assigned scores of the disordered tendencies of the sequences between 0 and 1, with scores higher than 0.5 indicating disorder. The amino acid sequence of FGF5 contains one IDR. e Confocal microscopy images of the assembly status of 5 μmol/L purified rFGF5-mCherry, rFGF5s-mCherry, or rΔIDR-mCherry with 0 or 10% PEG. Scale bar = 5 µm. f Images of purified protein colocalization assay on the cell surface via confocal microscopy and representative curves describing the distribution of the relative fluorescence intensities of FGFBP1 (green) and FGF5 or FGF5s (red). Top two panels: rFGFBP1-EGFP (5 nmol/L) with rFGF5-mCherry (20 nmol/L) or rFGF5s-mCherry (10 nmol/L). Bottom three panels: rFGFBP1-EGFP (5 nmol/L) with rFGF5-mCherry (20 nmol/L) and different amounts of rFGF5s (10, 20, or 40 nmol/L). Scale bar = 5 µm. g Representative albumin (ALB, a hepatocellular function marker) immunofluorescence of human liver organoids (HLOs) in the indicated groups. h Measurement of ALB secretion in HLOs ( n = 3). i Size calculation of HLOs in the indicated groups (CON, n = 146; rFGFBP1, n = 157; rFGFBP1 + rFGF5, n = 184). * P < 0.05, *** P < 0.001. FGF5 fibroblast growth factor 5, FGF5s short form of FGF5, FGFBP1 fibroblast growth factor binding protein 1, LLPS liquid–liquid phase separation, IDR intrinsically disordered region, PEG polyethylene glycol, EGFP enhanced green fluorescent protein, DIC differential interference contrast, DAPI 4’,6-diamidino-2-phenylindole, SP signal peptide
Antibody Rabbit Anti Brdu, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibody rabbit anti brdu/product/Rockland Immunochemicals
Average 94 stars, based on 1 article reviews
antibody rabbit anti brdu - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

99
Danaher Inc brdu cell proliferation assay kit
a , b TUNEL staining ( a ) and quantitation ( b ) to assess apoptosis in the epidermis and hair follicle of mice 72 h post DMBA/TPA one-time treatment. Scale bar = 50 µm. Shown is mean and SD of 5 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, *** p < 0.001. c , d <t>BrdU</t> staining ( c ) and quantitation ( d ) to assess <t>proliferation</t> in the epidermis and hair follicle of mice 48 h post DMBA/TPA one-time treatment. Scale bar = 100 µm. Shown is mean and SD of 3 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ns = not significant. e , f BrdU staining ( e ) and quantitation ( f ) in the epidermis adjacent to the skin lesions after 8 weeks of DMBA/TPA treatment of mice from each genotype. Scale bar = 50 µm. Shown is mean and SD of 5 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ** p < 0.01, *** p < 0.001. g , h TUNEL staining ( g ) and quantitation ( h ) to assess apoptosis in the epidermis and hair follicle of mice 8 weeks post DMBA/TPA treatment. Scale bar = 100 µm. Shown is mean and SD of 3 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ns = not significant.
Brdu Cell Proliferation Assay Kit, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brdu cell proliferation assay kit/product/Danaher Inc
Average 99 stars, based on 1 article reviews
brdu cell proliferation assay kit - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

93
Novus Biologicals sheep anti brdu
a , b TUNEL staining ( a ) and quantitation ( b ) to assess apoptosis in the epidermis and hair follicle of mice 72 h post DMBA/TPA one-time treatment. Scale bar = 50 µm. Shown is mean and SD of 5 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, *** p < 0.001. c , d <t>BrdU</t> staining ( c ) and quantitation ( d ) to assess <t>proliferation</t> in the epidermis and hair follicle of mice 48 h post DMBA/TPA one-time treatment. Scale bar = 100 µm. Shown is mean and SD of 3 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ns = not significant. e , f BrdU staining ( e ) and quantitation ( f ) in the epidermis adjacent to the skin lesions after 8 weeks of DMBA/TPA treatment of mice from each genotype. Scale bar = 50 µm. Shown is mean and SD of 5 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ** p < 0.01, *** p < 0.001. g , h TUNEL staining ( g ) and quantitation ( h ) to assess apoptosis in the epidermis and hair follicle of mice 8 weeks post DMBA/TPA treatment. Scale bar = 100 µm. Shown is mean and SD of 3 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ns = not significant.
Sheep Anti Brdu, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sheep anti brdu/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
sheep anti brdu - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

99
Danaher Inc rabbit antibodies against pam
a , b TUNEL staining ( a ) and quantitation ( b ) to assess apoptosis in the epidermis and hair follicle of mice 72 h post DMBA/TPA one-time treatment. Scale bar = 50 µm. Shown is mean and SD of 5 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, *** p < 0.001. c , d <t>BrdU</t> staining ( c ) and quantitation ( d ) to assess <t>proliferation</t> in the epidermis and hair follicle of mice 48 h post DMBA/TPA one-time treatment. Scale bar = 100 µm. Shown is mean and SD of 3 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ns = not significant. e , f BrdU staining ( e ) and quantitation ( f ) in the epidermis adjacent to the skin lesions after 8 weeks of DMBA/TPA treatment of mice from each genotype. Scale bar = 50 µm. Shown is mean and SD of 5 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ** p < 0.01, *** p < 0.001. g , h TUNEL staining ( g ) and quantitation ( h ) to assess apoptosis in the epidermis and hair follicle of mice 8 weeks post DMBA/TPA treatment. Scale bar = 100 µm. Shown is mean and SD of 3 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ns = not significant.
Rabbit Antibodies Against Pam, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit antibodies against pam/product/Danaher Inc
Average 99 stars, based on 1 article reviews
rabbit antibodies against pam - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

95
Proteintech anti brdu conjugated beads
a , b TUNEL staining ( a ) and quantitation ( b ) to assess apoptosis in the epidermis and hair follicle of mice 72 h post DMBA/TPA one-time treatment. Scale bar = 50 µm. Shown is mean and SD of 5 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, *** p < 0.001. c , d <t>BrdU</t> staining ( c ) and quantitation ( d ) to assess <t>proliferation</t> in the epidermis and hair follicle of mice 48 h post DMBA/TPA one-time treatment. Scale bar = 100 µm. Shown is mean and SD of 3 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ns = not significant. e , f BrdU staining ( e ) and quantitation ( f ) in the epidermis adjacent to the skin lesions after 8 weeks of DMBA/TPA treatment of mice from each genotype. Scale bar = 50 µm. Shown is mean and SD of 5 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ** p < 0.01, *** p < 0.001. g , h TUNEL staining ( g ) and quantitation ( h ) to assess apoptosis in the epidermis and hair follicle of mice 8 weeks post DMBA/TPA treatment. Scale bar = 100 µm. Shown is mean and SD of 3 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ns = not significant.
Anti Brdu Conjugated Beads, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti brdu conjugated beads/product/Proteintech
Average 95 stars, based on 1 article reviews
anti brdu conjugated beads - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

93
Novus Biologicals anti brdu
a , b TUNEL staining ( a ) and quantitation ( b ) to assess apoptosis in the epidermis and hair follicle of mice 72 h post DMBA/TPA one-time treatment. Scale bar = 50 µm. Shown is mean and SD of 5 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, *** p < 0.001. c , d <t>BrdU</t> staining ( c ) and quantitation ( d ) to assess <t>proliferation</t> in the epidermis and hair follicle of mice 48 h post DMBA/TPA one-time treatment. Scale bar = 100 µm. Shown is mean and SD of 3 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ns = not significant. e , f BrdU staining ( e ) and quantitation ( f ) in the epidermis adjacent to the skin lesions after 8 weeks of DMBA/TPA treatment of mice from each genotype. Scale bar = 50 µm. Shown is mean and SD of 5 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ** p < 0.01, *** p < 0.001. g , h TUNEL staining ( g ) and quantitation ( h ) to assess apoptosis in the epidermis and hair follicle of mice 8 weeks post DMBA/TPA treatment. Scale bar = 100 µm. Shown is mean and SD of 3 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ns = not significant.
Anti Brdu, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti brdu/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
anti brdu - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology bromo
a , b TUNEL staining ( a ) and quantitation ( b ) to assess apoptosis in the epidermis and hair follicle of mice 72 h post DMBA/TPA one-time treatment. Scale bar = 50 µm. Shown is mean and SD of 5 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, *** p < 0.001. c , d <t>BrdU</t> staining ( c ) and quantitation ( d ) to assess <t>proliferation</t> in the epidermis and hair follicle of mice 48 h post DMBA/TPA one-time treatment. Scale bar = 100 µm. Shown is mean and SD of 3 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ns = not significant. e , f BrdU staining ( e ) and quantitation ( f ) in the epidermis adjacent to the skin lesions after 8 weeks of DMBA/TPA treatment of mice from each genotype. Scale bar = 50 µm. Shown is mean and SD of 5 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ** p < 0.01, *** p < 0.001. g , h TUNEL staining ( g ) and quantitation ( h ) to assess apoptosis in the epidermis and hair follicle of mice 8 weeks post DMBA/TPA treatment. Scale bar = 100 µm. Shown is mean and SD of 3 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ns = not significant.
Bromo, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bromo/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
bromo - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

Image Search Results


FGF5 and FGF5s compete for binding to FGFBP1 via LLPS and regulate liver regeneration. a BrdU cell proliferation assay results to detect cell proliferation ability in AML12 cells overexpressing the 18 FGFs and treated with rFGFBP1 (10 ng/ml) or rFGFBP1 and FGFBP1Ab (2 μg/ml) ( n = 3). b Hepatic protein levels of FGF5 and FGF5s at the indicated times after partial (2/3) hepatectomy (PHx), with the corresponding quantification ( n = 2). c Representative liver FGFBP1 and FGF5 immunofluorescence results 24 h after acetaminophen (APAP) or saline administration. d Domain structure and the intrinsically disordered tendency of mouse FGF5 and FGF5s. IUPred assigned scores of the disordered tendencies of the sequences between 0 and 1, with scores higher than 0.5 indicating disorder. The amino acid sequence of FGF5 contains one IDR. e Confocal microscopy images of the assembly status of 5 μmol/L purified rFGF5-mCherry, rFGF5s-mCherry, or rΔIDR-mCherry with 0 or 10% PEG. Scale bar = 5 µm. f Images of purified protein colocalization assay on the cell surface via confocal microscopy and representative curves describing the distribution of the relative fluorescence intensities of FGFBP1 (green) and FGF5 or FGF5s (red). Top two panels: rFGFBP1-EGFP (5 nmol/L) with rFGF5-mCherry (20 nmol/L) or rFGF5s-mCherry (10 nmol/L). Bottom three panels: rFGFBP1-EGFP (5 nmol/L) with rFGF5-mCherry (20 nmol/L) and different amounts of rFGF5s (10, 20, or 40 nmol/L). Scale bar = 5 µm. g Representative albumin (ALB, a hepatocellular function marker) immunofluorescence of human liver organoids (HLOs) in the indicated groups. h Measurement of ALB secretion in HLOs ( n = 3). i Size calculation of HLOs in the indicated groups (CON, n = 146; rFGFBP1, n = 157; rFGFBP1 + rFGF5, n = 184). * P < 0.05, *** P < 0.001. FGF5 fibroblast growth factor 5, FGF5s short form of FGF5, FGFBP1 fibroblast growth factor binding protein 1, LLPS liquid–liquid phase separation, IDR intrinsically disordered region, PEG polyethylene glycol, EGFP enhanced green fluorescent protein, DIC differential interference contrast, DAPI 4’,6-diamidino-2-phenylindole, SP signal peptide

Journal: Military Medical Research

Article Title: Glucocorticoids trigger muscle-liver crosstalk to attenuate acute liver injury and promote liver regeneration via the FGF6-FGFBP1 axis

doi: 10.1186/s40779-025-00618-y

Figure Lengend Snippet: FGF5 and FGF5s compete for binding to FGFBP1 via LLPS and regulate liver regeneration. a BrdU cell proliferation assay results to detect cell proliferation ability in AML12 cells overexpressing the 18 FGFs and treated with rFGFBP1 (10 ng/ml) or rFGFBP1 and FGFBP1Ab (2 μg/ml) ( n = 3). b Hepatic protein levels of FGF5 and FGF5s at the indicated times after partial (2/3) hepatectomy (PHx), with the corresponding quantification ( n = 2). c Representative liver FGFBP1 and FGF5 immunofluorescence results 24 h after acetaminophen (APAP) or saline administration. d Domain structure and the intrinsically disordered tendency of mouse FGF5 and FGF5s. IUPred assigned scores of the disordered tendencies of the sequences between 0 and 1, with scores higher than 0.5 indicating disorder. The amino acid sequence of FGF5 contains one IDR. e Confocal microscopy images of the assembly status of 5 μmol/L purified rFGF5-mCherry, rFGF5s-mCherry, or rΔIDR-mCherry with 0 or 10% PEG. Scale bar = 5 µm. f Images of purified protein colocalization assay on the cell surface via confocal microscopy and representative curves describing the distribution of the relative fluorescence intensities of FGFBP1 (green) and FGF5 or FGF5s (red). Top two panels: rFGFBP1-EGFP (5 nmol/L) with rFGF5-mCherry (20 nmol/L) or rFGF5s-mCherry (10 nmol/L). Bottom three panels: rFGFBP1-EGFP (5 nmol/L) with rFGF5-mCherry (20 nmol/L) and different amounts of rFGF5s (10, 20, or 40 nmol/L). Scale bar = 5 µm. g Representative albumin (ALB, a hepatocellular function marker) immunofluorescence of human liver organoids (HLOs) in the indicated groups. h Measurement of ALB secretion in HLOs ( n = 3). i Size calculation of HLOs in the indicated groups (CON, n = 146; rFGFBP1, n = 157; rFGFBP1 + rFGF5, n = 184). * P < 0.05, *** P < 0.001. FGF5 fibroblast growth factor 5, FGF5s short form of FGF5, FGFBP1 fibroblast growth factor binding protein 1, LLPS liquid–liquid phase separation, IDR intrinsically disordered region, PEG polyethylene glycol, EGFP enhanced green fluorescent protein, DIC differential interference contrast, DAPI 4’,6-diamidino-2-phenylindole, SP signal peptide

Article Snippet: Cell proliferation was detected using a BrdU Cell Proliferation Assay Kit (6813S, Cell Signaling Technology, MA, USA) according to the manufacturer’s instructions.

Techniques: Binding Assay, BrdU Cell Proliferation Assay, Immunofluorescence, Saline, Sequencing, Confocal Microscopy, Purification, Fluorescence, Marker

a , b TUNEL staining ( a ) and quantitation ( b ) to assess apoptosis in the epidermis and hair follicle of mice 72 h post DMBA/TPA one-time treatment. Scale bar = 50 µm. Shown is mean and SD of 5 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, *** p < 0.001. c , d BrdU staining ( c ) and quantitation ( d ) to assess proliferation in the epidermis and hair follicle of mice 48 h post DMBA/TPA one-time treatment. Scale bar = 100 µm. Shown is mean and SD of 3 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ns = not significant. e , f BrdU staining ( e ) and quantitation ( f ) in the epidermis adjacent to the skin lesions after 8 weeks of DMBA/TPA treatment of mice from each genotype. Scale bar = 50 µm. Shown is mean and SD of 5 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ** p < 0.01, *** p < 0.001. g , h TUNEL staining ( g ) and quantitation ( h ) to assess apoptosis in the epidermis and hair follicle of mice 8 weeks post DMBA/TPA treatment. Scale bar = 100 µm. Shown is mean and SD of 3 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ns = not significant.

Journal: Oncogenesis

Article Title: Altering MYC phosphorylation in the epidermis increases the stem cell population and contributes to the development, progression, and metastasis of squamous cell carcinoma

doi: 10.1038/s41389-020-00261-3

Figure Lengend Snippet: a , b TUNEL staining ( a ) and quantitation ( b ) to assess apoptosis in the epidermis and hair follicle of mice 72 h post DMBA/TPA one-time treatment. Scale bar = 50 µm. Shown is mean and SD of 5 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, *** p < 0.001. c , d BrdU staining ( c ) and quantitation ( d ) to assess proliferation in the epidermis and hair follicle of mice 48 h post DMBA/TPA one-time treatment. Scale bar = 100 µm. Shown is mean and SD of 3 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ns = not significant. e , f BrdU staining ( e ) and quantitation ( f ) in the epidermis adjacent to the skin lesions after 8 weeks of DMBA/TPA treatment of mice from each genotype. Scale bar = 50 µm. Shown is mean and SD of 5 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ** p < 0.01, *** p < 0.001. g , h TUNEL staining ( g ) and quantitation ( h ) to assess apoptosis in the epidermis and hair follicle of mice 8 weeks post DMBA/TPA treatment. Scale bar = 100 µm. Shown is mean and SD of 3 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, ns = not significant.

Article Snippet: Briefly, the paraffin slides were de-paraffinized, incubated with TdT enzyme at 37 °C for 1 h, washed in TACS 2 TdT stop buffer for 10 min, incubated with streptavidin-HRP for 30 min, and counterstained with methanol green for 10 min. For proliferation analysis, a BrdU cell proliferation Assay Kit (BioVision, Cat. K306), according to the manufacturer’s protocol.

Techniques: TUNEL Assay, Staining, Quantitation Assay, Comparison, BrdU Staining

a , b Long-term label-retaining cell analysis in control, MYC WT , or MYC T58A mice. Retention of BrdU was assessed 75 days after injection through immunofluorescent staining for BrdU (red) shown in ( a ) and quantification of percent of cells positive for BrdU shown in ( b ). p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, *** p < 0.001. c Immunofluorescence images of skin from the long-term label-retaining analysis stained with anti-CD34 (red). White arrows indicate positive cells in hair follicles. DAPI (blue) is nuclear counterstain. d Quantitation of CD34 staining from (c). Significance was determined by one-way ANOVA, followed by Tukey’s multiple comparison test, ** p < 0.01, *** p < 0.001. e qRT-PCR for Lin28B expression in skin of mice used in long-term label-retaining analysis (normal skin). p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, * p < 0.05, ** p < 0.01. f Immunohistochemistry for CD34 staining in hair follicles from the hyperplastic skin of control, MYC WT , or MYC T58A mice 4 months after DMBA/TPA treatment. Scale bar = 50 µm. Insets are shown below. Red arrowheads indicate CD34 positive cells. Nonspecific staining in the sebaceous gland is indicated by asterisks. g Quantification of CD34 staining from mice as in ( f ). Shown is mean and SD of 5 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, * p < 0.05, *** p < 0.001. h qRT-PCR for expression of stem cell marker or signaling pathway genes, as indicated, in hyperplastic epidermis from DMBA/TPA-treated control, MYC WT , or MYC T58A mice. p -value is from a two-tailed Welch’s t -test. * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Oncogenesis

Article Title: Altering MYC phosphorylation in the epidermis increases the stem cell population and contributes to the development, progression, and metastasis of squamous cell carcinoma

doi: 10.1038/s41389-020-00261-3

Figure Lengend Snippet: a , b Long-term label-retaining cell analysis in control, MYC WT , or MYC T58A mice. Retention of BrdU was assessed 75 days after injection through immunofluorescent staining for BrdU (red) shown in ( a ) and quantification of percent of cells positive for BrdU shown in ( b ). p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, *** p < 0.001. c Immunofluorescence images of skin from the long-term label-retaining analysis stained with anti-CD34 (red). White arrows indicate positive cells in hair follicles. DAPI (blue) is nuclear counterstain. d Quantitation of CD34 staining from (c). Significance was determined by one-way ANOVA, followed by Tukey’s multiple comparison test, ** p < 0.01, *** p < 0.001. e qRT-PCR for Lin28B expression in skin of mice used in long-term label-retaining analysis (normal skin). p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, * p < 0.05, ** p < 0.01. f Immunohistochemistry for CD34 staining in hair follicles from the hyperplastic skin of control, MYC WT , or MYC T58A mice 4 months after DMBA/TPA treatment. Scale bar = 50 µm. Insets are shown below. Red arrowheads indicate CD34 positive cells. Nonspecific staining in the sebaceous gland is indicated by asterisks. g Quantification of CD34 staining from mice as in ( f ). Shown is mean and SD of 5 mice per genotype. p -value is from a one-way ANOVA, followed by Tukey’s multiple comparison test, * p < 0.05, *** p < 0.001. h qRT-PCR for expression of stem cell marker or signaling pathway genes, as indicated, in hyperplastic epidermis from DMBA/TPA-treated control, MYC WT , or MYC T58A mice. p -value is from a two-tailed Welch’s t -test. * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: Briefly, the paraffin slides were de-paraffinized, incubated with TdT enzyme at 37 °C for 1 h, washed in TACS 2 TdT stop buffer for 10 min, incubated with streptavidin-HRP for 30 min, and counterstained with methanol green for 10 min. For proliferation analysis, a BrdU cell proliferation Assay Kit (BioVision, Cat. K306), according to the manufacturer’s protocol.

Techniques: Cell Analysis, Control, Injection, Staining, Comparison, Immunofluorescence, Quantitation Assay, Quantitative RT-PCR, Expressing, Immunohistochemistry, Marker, Two Tailed Test